摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6,7-二氯-4-甲基-3-苯基-2H-苯并吡喃-2-酮 | 288399-87-1

中文名称
6,7-二氯-4-甲基-3-苯基-2H-苯并吡喃-2-酮
中文别名
——
英文名称
6,7-Dichloro-4-methyl-3-phenylcoumarin
英文别名
6,7-dichloro-4-methyl-3-phenylchromen-2-one
6,7-二氯-4-甲基-3-苯基-2H-苯并吡喃-2-酮化学式
CAS
288399-87-1
化学式
C16H10Cl2O2
mdl
——
分子量
305.2
InChiKey
BPTRXIYZNCXNHE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    466.4±45.0 °C(Predicted)
  • 密度:
    1.379±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    20
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • POLYPEPTIDES AND THEIR USE
    申请人:Novabiotics Limited
    公开号:EP2825261A1
    公开(公告)日:2015-01-21
  • USE OF COUMARIN DERIVATIVES IN ANTIFUNGAL THERAPY
    申请人:Stewart Colin
    公开号:US20100267653A1
    公开(公告)日:2010-10-21
    The invention provides coumarin compounds, in particular glycosidic coumarin compounds, useful in the treatment of dermatophyte fungal infections.
  • Polypeptides and Their Use
    申请人:O'NEIL Deborah
    公开号:US20140155321A1
    公开(公告)日:2014-06-05
    The present invention relates to a polypeptide or a product comprising said polypeptide for use in the treatment and/or prevention of a fungal infection caused by Malassezia spp. and/or a Malassezia spp associated condition wherein the polypeptide comprises a sequence of about 25 to 200 amino acids wherein substantially all of the amino acids in said sequence are lysine; pharmaceutical compositions comprising said polypeptide or product and uses thereof.
  • [EN] POLYPEPTIDES AND THEIR USE<br/>[FR] POLYPEPTIDES ET LEUR UTILISATION
    申请人:NOVABIOTICS LTD
    公开号:WO2013136040A1
    公开(公告)日:2013-09-19
    The present invention relates to a polypeptide or a product comprising said polypeptide for use in the treatment and/or prevention of a fungal infection caused by Malassezia spp. and/or a Malassezia spp associated condition wherein the polypeptide comprises a sequence of about 25 to 200 amino acids wherein substantially all of the amino acids in said sequence are lysine; pharmaceutical compositions comprising said polypeptide or product and uses thereof.
查看更多